Terms: = Liver cancer AND PRRX1, ENSG00000116132, 5396
15 results:
1. A
Nygaard V; Ree AH; Dagenborg VJ; Børresen-Dale AL; Edwin B; Fretland ÅA; Grzyb K; Haugen MH; Mælandsmo GM; Flatmark K
Cancer Res Commun; 2023 Feb; 3(2):235-244. PubMed ID: 36968142
[TBL] [Abstract] [Full Text] [Related]
2. Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.
Zheng J; Shao M; Yang W; Ren J; Chen X; Yang H
Int Immunopharmacol; 2022 Nov; 112():109244. PubMed ID: 36126410
[TBL] [Abstract] [Full Text] [Related]
3. Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes.
Piorońska W; Nwosu ZC; Han M; Büttner M; Ebert MP; Dooley S; Meyer C
BMC Cancer; 2021 Sep; 21(1):1006. PubMed ID: 34496784
[TBL] [Abstract] [Full Text] [Related]
4. prrx1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract] [Full Text] [Related]
5. Group-based trajectory analysis of postoperative pain and outcomes after liver cancer surgery.
Teng WN; Wu HL; Tai YH; Lei HJ; Tsou MY; Chang KY
J Chin Med Assoc; 2021 Jan; 84(1):95-100. PubMed ID: 33177401
[TBL] [Abstract] [Full Text] [Related]
6. The rs7911488-T allele promotes the growth and metastasis of colorectal cancer through modulating miR-1307/prrx1.
Yang M; Liu X; Meng F; Zhang Y; Wang M; Chen Y; Guo X; Chen W; Wang W
Cell Death Dis; 2020 Aug; 11(8):651. PubMed ID: 32811812
[TBL] [Abstract] [Full Text] [Related]
7. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of prrx1.
Tang Y; Lu Y; Chen Y; Luo L; Cai L; Peng B; Huang W; Liao H; Zhao L; Pan M
J Exp Clin Cancer Res; 2019 Nov; 38(1):473. PubMed ID: 31752959
[TBL] [Abstract] [Full Text] [Related]
8. prrx1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
[TBL] [Abstract] [Full Text] [Related]
9. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of prrx1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.
Fan M; Shen J; Liu H; Wen Z; Yang J; Yang P; Liu K; Chang Y; Duan J; Lu K
Oncol Rep; 2017 Aug; 38(2):1083-1090. PubMed ID: 28677793
[TBL] [Abstract] [Full Text] [Related]
11. cancer Incidence among Heart, Kidney, and liver Transplant Recipients in Taiwan.
Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
[TBL] [Abstract] [Full Text] [Related]
12. Folate deficient tumor microenvironment promotes epithelial-to-mesenchymal transition and cancer stem-like phenotypes.
Su YH; Huang WC; Huang TH; Huang YJ; Sue YK; Huynh TT; Hsiao M; Liu TZ; Wu AT; Lin CM
Oncotarget; 2016 May; 7(22):33246-56. PubMed ID: 27119349
[TBL] [Abstract] [Full Text] [Related]
13. prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
[TBL] [Abstract] [Full Text] [Related]
14. A NSQIP Analysis of MELD and Perioperative Outcomes in General Surgery.
Zielsdorf SM; Kubasiak JC; Janssen I; Myers JA; Luu MB
Am Surg; 2015 Aug; 81(8):755-9. PubMed ID: 26215235
[TBL] [Abstract] [Full Text] [Related]
15. Downregulation of prrx1 Confers cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
[TBL] [Abstract] [Full Text] [Related]
